Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

The mRNA vaccines for HIV “are not at all dead in the water,” Kublin told me. If needed, scientists could tweak the vaccine recipe, or combine the mRNA approach with another technology.

Researchers will monitor 56 HIV-negative adults for six months in the Phase 1 clinical trial, typically the first step in a long road to study the safety and efficacy of a vaccine.

The first mRNA-based HIV vaccine is about to start human trials The same system Moderna used for its COVID vaccine may also be able to help prevent HIV. Sara Chodosh Aug 18, 2021 11:24 AM EDT ...

Moderna's HIV vaccine candidate, which uses the same mRNA technology as the company's COVID-19 vaccine, is expected to begin clinical trials as soon as next week.

An experimental HIV vaccine based on mRNA -- the same platform technology used in two highly effective COVID-19 vaccines -- shows promise in mice and non-human primates, according to scientists ...